If the mRNA and/or Adenovector approaches prove safe (data may be available in 4/2023) the tech is pretty easy to duplicate. One possible good outcome of the fake panic is moving mRNA up about 5 years. The adenovector was in use on ebola and dengue just recently and it may have been raced forward but nt as much a mRNA. mRNA approach t…
If the mRNA and/or Adenovector approaches prove safe (data may be available in 4/2023) the tech is pretty easy to duplicate. One possible good outcome of the fake panic is moving mRNA up about 5 years. The adenovector was in use on ebola and dengue just recently and it may have been raced forward but nt as much a mRNA. mRNA approach to cancer is benefitting as well.
a\Also Moderna's mRNA was involved in DARPA Pandemic Prevention Platform project, so it may have some taxpayer interest in the patent.
If the mRNA and/or Adenovector approaches prove safe (data may be available in 4/2023) the tech is pretty easy to duplicate. One possible good outcome of the fake panic is moving mRNA up about 5 years. The adenovector was in use on ebola and dengue just recently and it may have been raced forward but nt as much a mRNA. mRNA approach to cancer is benefitting as well.
a\Also Moderna's mRNA was involved in DARPA Pandemic Prevention Platform project, so it may have some taxpayer interest in the patent.